PROGRESSIVE MCRPC

Clinical trials for PROGRESSIVE MCRPC explained in plain language.

Never miss a new study

Get alerted when new PROGRESSIVE MCRPC trials appear

Sign up with your email to follow new studies for PROGRESSIVE MCRPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Radioactive drug trial offers new hope for men with Tough-to-Treat prostate cancer

Disease control Completed

This study tested whether adding a radioactive drug (I-131-1095) to standard medication (enzalutamide) could better control advanced prostate cancer that had worsened on a prior drug (abiraterone). It involved 120 men whose cancer had spread and was visible on a special PSMA scan…

Matched conditions: PROGRESSIVE MCRPC

Phase: PHASE2 • Sponsor: Progenics Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

PROGRESSIVE MCRPC

Get alerted when new PROGRESSIVE MCRPC trials appear

Radioactive drug trial offers new hope for men with Tough-to-Treat prostate cancer